0.00
Eyenovia Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Eyenovia Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies that target new indications or new combinations.
See More
Previous Close:
$15.82
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$11.76M
Revenue:
$31,800
Net Income/Loss:
$-37.83M
P/E Ratio:
0.00
EPS:
-0.71
Net Cash Flow:
$-30.64M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
Eyenovia Inc Stock (EYEN) Company Profile
Name
Eyenovia Inc
Sector
Industry
Phone
813-766-9539
Address
295 MADISON AVENUE,, NEW YORK, NY
Compare EYEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
EYEN
Eyenovia Inc
|
0.00 | 11.76M | 31,800 | -37.83M | -30.64M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.39 | 108.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
463.43 | 60.82B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.95 | 61.02B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
817.32 | 50.01B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
310.81 | 34.05B | 4.56B | -176.77M | 225.30M | -1.7177 |
Eyenovia Inc Stock (EYEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-18-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-01-21 | Initiated | Northland Capital | Outperform |
| Feb-03-20 | Downgrade | Oppenheimer | Outperform → Perform |
Eyenovia Inc Stock (EYEN) Latest News
Has Eyenovia Inc. found a price floorEarnings Beat & Risk Controlled Swing Trade Alerts - newser.com
Will Eyenovia Inc. stock pay special dividendsJuly 2025 Sector Moves & Real-Time Chart Pattern Alerts - newser.com
Analyzing Eyenovia Inc. with risk reward ratio chartsMarket Growth Summary & Reliable Breakout Stock Forecasts - newser.com
Can volume confirm reversal in Eyenovia Inc.2025 Analyst Calls & Reliable Trade Execution Plans - newser.com
What institutional flow reveals about Eyenovia Inc.July 2025 Price Swings & Community Trade Idea Sharing Platform - newser.com
Is Eyenovia Inc. stock in correction or buying zoneBuy Signal & Free Daily Entry Point Trade Alerts - newser.com
Is a relief rally coming for Eyenovia Inc. holders2025 Stock Rankings & Daily Stock Momentum Reports - newser.com
How interest rate cuts could boost Eyenovia Inc. stockQuarterly Profit Summary & Smart Allocation Stock Reports - newser.com
What margin trends mean for Eyenovia Inc. stockMarket Risk Report & AI Powered Market Trend Analysis - newser.com
What makes Eyenovia Inc. stock attractive to growth fundsPortfolio Gains Summary & High Accuracy Trade Signal Alerts - newser.com
What technical signals suggest for Eyenovia Inc. stock2025 Trading Recap & Intraday High Probability Setup Alerts - newser.com
Earnings visualization tools for Eyenovia Inc.July 2025 Final Week & Weekly Setup with High ROI Potential - newser.com
Backtesting results for Eyenovia Inc. trading strategiesJuly 2025 Weekly Recap & Reliable Intraday Trade Plans - newser.com
How to build a dashboard for Eyenovia Inc. stock2025 Short Interest & Daily Profit Focused Screening - newser.com
Chart based analysis of Eyenovia Inc. trendsWeekly Risk Report & Safe Entry Momentum Tips - newser.com
Eyenovia Inc Stock (EYEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):